Health & Fitness

Novo Nordisk Launches Wegovy Pill in US: First Oral GLP-1 Weight Loss Drug Hits Market January 2026

Novo Nordisk launched the Wegovy pill on January 5, 2026 – the first oral GLP-1 for weight loss. …

FDA Approves First-Ever Oral GLP-1 Pill: Wegovy Pill Launches New Era in Weight Loss Drugs 2025

The FDA has approved Novo Nordisk's Wegovy pill, the first oral GLP-1 medication for weight loss. Discover how …

COVID-19 Vaccination Linked to 25% Lower All-Cause Mortality Risk: Groundbreaking 2025 French Study Reveals Long-Term Benefits

A massive new study of nearly 28 million adults shows that people vaccinated against COVID-19 have a significantly …

Your Brain Doesn't Reach Adulthood Until Age 32: Groundbreaking Study Reveals Five Phases of Brain Development

Think you became an adult at 18? Science says otherwise. A landmark Cambridge University study analyzing 4,000 brain …

Higher Stroke Risk Linked to Consuming Three or More Alcoholic Drinks Daily, New Harvard Study Finds

A groundbreaking Harvard study reveals that heavy drinkers consuming three or more alcoholic drinks per day face a …

Melatonin and Heart Health: New Study Sparks Concern, But Experts Urge Calm

A large observational study links melatonin use to higher heart failure risk, but causality isn’t proven and experts …